Aim: Anemia is a prevalent condition in older people, and associated with increased morbidity and mortality. Previous studies identified various causes of anemia in this population. We aimed to determine the frequency and main causes of persistent or recurrent anemia in participants 2 years after their inclusion in the São Paulo Ageing & Health Study (SPAH).
Methods: The SPAH is a cohort study of 2072 individuals aged 65 years or older living in poor neighborhoods of São Paulo, Brazil. A total of 2 years after inclusion, participants were reassessed; those with anemia at baseline were eligible for this ancillary study. Individuals were invited to a medical re-evaluation, including taking blood samples to determine serum iron, ferritin, total iron-binding capacity, folic acid, vitamin B(12), creatinine and transferrin saturation levels, and blood cell and reticulocyte counts. Anemia diagnosis was based on WHO criteria. Information about cause of death before follow-up assessment was obtained from death certificates.
Results: Of the 203 participants with anemia at inclusion, 97 (47.8%) were reassessed, 48 (23.6%) died before follow-up assessment, 33 (16.3%) refused to participate and 25 (12.3%) were not traced. A total of 57 (58.8%) of the 97 re-evaluated participants had persistent or recurrent anemia. Lower baseline hemoglobin was a predictor of anemia during follow up. Major causes of persistent or recurrent anemia at follow up were renal disease (62%) and chronic inflammation (35%).
Conclusion: Anemia was a prevalent and persistent disease in this low-income sample of older individuals. Micronutrient-related anemia, chronic blood loss and renal disease are important mechanisms for perpetuating low hemoglobin levels.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1447-0594.2012.00888.x | DOI Listing |
Genet Test Mol Biomarkers
January 2025
Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran.
Fanconi anemia (FA) is a rare genetic disorder that affects multiple systems in the body and is the most prevalent congenital syndrome, leading to bone marrow failure. Twenty-two genes have been identified as contributors to the disease. Significant advancements have been made in the past 2 decades in understanding the genetic and pathophysiological processes involved.
View Article and Find Full Text PDFAlthough iron deficiency anemia is common, interpreting iron laboratory test results can be challenging in patients with comorbidities. We aimed to study the accuracy of common iron biomarkers compared with bone marrow iron staining in a large retrospective dataset of hematological patients. We collected from 6610 patients (median age 66 years) results of iron staining, with their concurrent ferritin, transferrin saturation, soluble transferrin receptor, transferrin, hemoglobin, and mean red blood cell volume results from Helsinki University Hospital electronic health records.
View Article and Find Full Text PDFJ Bone Joint Surg Am
January 2025
Department of Orthopaedic Oncology, Learning Cancer Outcome Research Program, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Background: Comorbidity indices are used to help to estimate patients' length of hospital stay, care costs, outcomes, and mortality. Increasingly, they are considered in reimbursement models. The applicability of comorbidity indices to patients undergoing orthopaedic oncology surgery has not been studied.
View Article and Find Full Text PDFLangenbecks Arch Surg
January 2025
Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Purpose: Optimal management of retroperitoneal soft tissue sarcoma (RPS) often requires extensive tumor resections, frequently involving gastrointestinal organs. The impact of these procedures on the nutritional status and hemoglobin (Hb) levels of RPS patients remain unexplored. In this study, we aimed to evaluate preoperative nutritional status as well as the prevalence of anemia in RPS patients, and to investigate longitudinal changes throughout the disease course in order to identify potential strategies for prehabilitation.
View Article and Find Full Text PDFInn Med (Heidelb)
January 2025
MVZ Nephrocare Mettmann GmbH, Gartenstr. 4-8, 40822, Mettmann, Deutschland.
Recognizing anemia and thrombpenia in acute and emergency medicine is easy. Acute (microangiopathic hemolytic) anemia and thrombopenia can be a sign of thrombotic microangiopathy (TMA). TMA syndromes are potentially life-threatening diseases.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!